Ori Biotech raises 拢75m for cell and gene therapy platform
Ori Biotech has raised around 拢75 million to launch its cell and gene therapy manufacturing platform into the market. The Ori platform enables therapy developers, contract manufacturers and academic researchers to transition from pre-clinical process discovery through clinical trials to commercial scale.聽 The London company is also launching its Lightspeed Early Access Program, allowing select … Continue reading Ori Biotech raises 拢75m for cell and gene therapy platform
